Detouring destruction: A role for inhibitory neuronal activity in preventing neuronal loss - Implications for Alzheimer's disease

Journal of the American Osteopathic Association

Volumn 101, Issue 12 SUPPL. I, 2001, Pages

  Graf, Robert A ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

amyloid; Alzheimer's disease; Benzodiazepine; Diazepam; Gamma aminobutyric acid; Hippocampus; Inhibition; Learning; Memory; Secretase; Vaccine; Valium

Indexed keywords

4 AMINOBUTYRIC ACID; AMYLOID BETA PROTEIN; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; DIAZEPAM; FLUMAZENIL; PICROTOXIN; TETRODOTOXIN;

ALZHEIMER DISEASE; BRAIN PROTECTION; CELL ACTIVITY; CELL LOSS; COGNITIVE DEFECT; DISEASE COURSE; ENZYME INHIBITION; HUMAN; MEDICAL RESEARCH; NERVE CELL INHIBITION; NERVE DEGENERATION; QUALITY OF LIFE; REVIEW; SENILE PLAQUE; TREATMENT PLANNING;

AGED; ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; NEURONS; NEUROPHARMACOLOGY;

EID: 0035571870     PISSN: 00986151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Experimental approaches and drugs in development for the treatment of dementia
2. Drugs for treatment of Alzheimar's disease
3. Review of the next generation of Alzheimer's disease therapeutics: Challenges for drug development
4. New approaches to diagnose and treat Alzheimer's disease: A glimpse of the future
5. Alzheimer's disease: Genes, proteins, and therapy
6. Presenilins as therapeutic targets for the treatment of Alzheimer's disease
7. Secretases as therapeutic targets for the treatment of Alzheimer's disease
8. Closing in on the amyloid cascade: Recent insights into the cell biology of Alzheimer's disease
9. Biochemical characterization of the gamma-secretase activity that produces β-amyloid peptides
10. Alzheimer's disease. Molecular consequences of presenilin-1 mutation
11. Immunization with a nontoxic/nonfibnillar amyloid-β, homologous peptide reduces Alzheimer's disease - Associated pathology in transgenic mice
12. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
13. Generation of auto-antibodies toward Alzheimer's disease vaccination
14. Neuronal apoptosis after CNS injury: The roles of glutamate and calcium
15. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
16. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise
17. The toxicity in vitro of β-amyloid protein
18. Inhibitory neuronal activity can compensate for adverse effects of β-amyloid in hippocampal neurons
19. Vulnerability of small GABAergic neurons in human β-amyloid pentapeptide
20. Density and pharmacology of α5 subunit-containing GABA(A) receptors are preserved in hippocampus of Alzheimer's disease patients
21. Diazepam can protect hipppocampal neurons from death due to exposure to β-amyloid peptides
22. Cognitive effects of flumazenil in patients with Alzheimer's disease
23. Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzediazepine